PubMed Health⌕ Search

PubMed · 14736465

Fracture fixation problems in osteoporosis.

Abstract

Osteoporosis, or loss of bone mass and microarchitectural deterioration of bone tissue, does not only enhance risk of fracture but also represents a problem in osteofixation of fractures in fracture treatment. Aging of the western population changes the epidemiology of fractures. An increasing socioeconomic interest in geriatric traumatology makes the need for much urgent study in the field of osteoporotic fractures self evident. It is no longer the province of only one medical group to look for fragmented solutions in the treatment of osteoporotic fractures. Efforts have to be united across professional boundaries to meet the challenge of this problem. Assessment of bone mineral may be used in evaluation of fracture risk but also in the choice of implant as well as in the design of implants used in fracture treatment. The differences in mechanical properties of different types of bone in the same individual have to be respected. Changes in the pattern of fractures and problems with implant anchorage in bone, due to a demographic increase in patients with osteoporosis remain problems requiring new solutions. Still basic principals in fracture treatment may not be eclipsed by new fixation devices.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Knut Strømsøe. 2004. Fracture fixation problems in osteoporosis.. https://doi.org/10.1016/j.injury.2003.08.019

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Escitalopram in the long-term treatment of major depressive disorder in elderly patients.

AIM: The primary aim was to investigate the long-term safety and tolerability of escitalopram (10 or 20 mg/day) treatment of elderly patients suffering from major depressive disorder. The secondary aim was to examine response to treatment, as measured by change in the Montgomery-Asberg Depression Rating Scale (MADRS) total score from study entry to each visit, using observed cases. METHOD: This extension trial included 225 patients who had completed an 8-week, double blind, placebo-controlled lead-in study, which was performed in outpatients in primary care and in specialist clinics. The intent-to-treat population comprised 223 patients. RESULTS: The overall withdrawal rate was 24%. The most common reason for withdrawal was adverse events (9%). The 5 most common adverse events were accidental injury, rhinitis, weight increase, arthralgia and coughing, with an incidence ranging from 8 to 13%. No new types of adverse events were reported in this extension study compared to the 8-week lead-in study. The mean weight increased from 69.7 kg at study entry to 70.3 kg at endpoint. The percentage of patients in remission (MADRS total score < or = 12) increased from 48% at study entry to 72% by week 52. CONCLUSION: Escitalopram demonstrated a favourable tolerability profile during 52 weeks of open-label treatment of elderly patients, with further improvement in depressive symptoms.

Accidental Falls↗

MRI of rupture of the spring ligament complex with talo-cuboid impaction.

The spring ligament complex is essential for the stability of the longitudinal arch of the foot and includes the ligaments between the calcaneus and the talus at the superomedial to inferoplantar aspect of the foot. Tears of the spring ligament complex are most commonly degenerative in etiology and secondary to concomitant abnormality of the posterior tibial tendon. We report MRI findings in a 30-year-old man who presented with traumatic rupture of the spring ligament complex, seen following dislocation of the talonavicular joint. We also describe the previously unreported MRI features of talo-cuboid impaction secondary to disruption of the spring ligament complex.

Accidental Falls↗